| Biomarker ID | 1019 |
| PMID | 23171880 |
| Year | 2012 |
| Biomarker | CRP |
| Biomarker Basis | Concentration Based (ng/ml) |
| Biomolecule | Protein |
| Source | Plasma |
| Subjects | Humans |
| Regulation | Upregulated in PCa (PCa: 2.5 , Normal: 2.1) |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 3.04 (95% CI: 1.28 - 7.23) |
| Effect on Pathways | Pathways include: Vitamin B12 metabolism, Selenium pathway, Folate metabolism, Interleukin-6 signaling pathway, Complement cascade |
| Experiment | PCa Vs Controls |
| Type of Biomarker | Diagnostic |
| Cohort | 52 cancer cases along with 63 controls were chosen for the study. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | [Odds Ratio: p=0.03]; [Regulation: p = 0.006] |
| Method Used | Immunometry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | CRP |